insights_auto
Why is IMRN down 2.59%?
Dive Deeperchevron_right
IMRN:NASDAQ
Immuron Ltd - ADR
$1.13
arrow_downward
-2.59%(-0.030) 1D
$1.12
arrow_downward
-0.88% (-0.0100)bedtimeAfter hours
Closed: Oct 1, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IMRN...
Open
$1.14
High
$1.18
Low
$1.12
Mkt. cap
8.78M
Avg. vol.
4.37M
Volume
53.40K
52-wk high
$2.38
52-wk low
$0.68
EPS
-$0.36
Beta
1.17
Shares outstanding
8.07M
No. of employees
8
Open
$1.14
High
$1.18
Low
$1.12
Mkt. cap
8.78M
Avg. vol.
4.37M
Volume
53.40K
52-wk high
$2.38
52-wk low
$0.68
EPS
-$0.36
Beta
1.17
Shares outstanding
8.07M
No. of employees
8
News stories
From web sources and news partners
Simply Wall Street
·
29 minutes ago
EquipmentShare.com (EQPT) Commits To 1 Gigawatt Of Power Capacity
Yahoo Finance
·
28 minutes ago
Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026
Investor's Business Daily
·
6 minutes ago
Twilio To Join S&P 500 Index
Fox Business
·
3 hours ago
October could be a huge month for the stock market. Here's why.
Profile
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
About Immuron Ltd - ADR
CEO-
Employees8
Founded1994
HeadquartersBlackburn North, Victoria, Australia
SectorBiotechnology
Websiteimmuron.com.au